Mn Services Vermogensbeheer B.V. Bristol Myers Squibb CO Transaction History

Mn Services Vermogensbeheer B.V.

$14.8 Billion
Q4 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 803,754 shares of BMY stock, worth $45.7 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

803,754

Previous 784,854 2.41%

Holding current value

$45.7 Million

Previous $40.6 Million 11.95%

% of portfolio

0.31%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$51.92 - $59.94 $981,288 - $1.13 Million	18,900 Added 2.41%	803,754 $45.5 Million
Q3 2024 Oct 30, 2024	SELL	$39.66 - $51.75 $769,403 - $1 Million	-19,400 Reduced 2.41%	784,854 $40.6 Million
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $740,600 - $975,016	-18,400 Reduced 2.24%	804,254 $33.4 Million
Q1 2024 Apr 29, 2024	SELL	$47.98 - $54.4 $8.42 Million - $9.54 Million	-175,400 Reduced 17.57%	822,654 $44.6 Million
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $1.29 Million - $1.54 Million	-26,600 Reduced 2.6%	998,054 $51.2 Million
Q3 2023 Oct 25, 2023	BUY	$57.89 - $64.73 $949,396 - $1.06 Million	16,400 Added 1.63%	1,024,654 $59.5 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $5.08 Million - $5.65 Million	-79,800 Reduced 7.33%	1,008,254 $64.5 Million
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $2.62 Million - $2.97 Million	39,900 Added 3.81%	1,088,054 $75.4 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $11 Million - $13 Million	-160,800 Reduced 13.3%	1,048,154 $75.4 Million
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $10,348 - $6.12 Million	-79,600 Reduced 6.18%	1,208,954 $85.9 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $22.9 Million - $25.2 Million	-314,800 Reduced 19.63%	1,288,554 $99.2 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $6.55 Million - $7.86 Million	-106,600 Reduced 6.23%	1,603,354 $117 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $1.93 Million - $2.25 Million	36,000 Added 2.15%	1,709,954 $107 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $1.83 Million - $2.14 Million	30,900 Added 1.88%	1,673,954 $99 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $21.3 Million - $23.2 Million	-343,800 Reduced 17.3%	1,643,054 $92.6 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $1.41 Million - $1.6 Million	24,400 Added 1.24%	1,986,854 $123 Million
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $2.22 Million - $2.46 Million	38,700 Added 2.01%	1,962,454 $118 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $3.93 Million - $4.6 Million	-71,700 Reduced 3.59%	1,923,754 $113 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $5.99 Million - $8.7 Million	-129,000 Reduced 6.07%	1,995,454 $111 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $33.6 Million - $43.9 Million	683,662 Added 47.45%	2,124,454 $136 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $25.9 Million - $30.7 Million	604,426 Added 72.27%	1,440,792 $73.1 Million
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $2.91 Million - $3.22 Million	-65,200 Reduced 7.23%	836,366 $37.9 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $383,520 - $457,300	8,500 Added 0.95%	901,566 $43 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $30.8 Million - $39.9 Million	630,792 Added 240.51%	893,066 $40.6 Million
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $270,431 - $305,025	4,900 Added 1.9%	262,274 $16.3 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $65,912 - $75,878	1,100 Added 0.43%	257,374 $16.3 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $923,076 - $1.01 Million	-15,400 Reduced 5.67%	256,274 $13.1 Million
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $15 Million - $17.3 Million	271,674	271,674 $17.3 Million

Others Institutions Holding BMY

# of Institutions

2,639

Shares Held

1.46B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Bristol Myers Squibb CO Transaction History